Speaking to CNBC-TV18, Kiran Mazumdar Shaw, CMD of Biocon said huge opportunities exist for Biocon in the US biosimilars market.
first published: Dec 6, 2016 12:52 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

